| |
Audit
|
Compensation
|
Nominating & Governance
|
Randy Gress
|
|
|
|
|
Chairman of the Board, Chief Executive Officer, President and Director Randolph Gress is Chairman of the Board, Chief Executive Officer, President and Director of Innophos. Mr. Gress joined Innophos as Chief Executive Officer and Director at the Company's inception in 2004. Previously, Mr. Gress joined Rhodia in 1997 and held various positions including Global President of Rhodia's Specialty Phosphates business and Vice President and General Manager of the Sulfuric Acid business. Prior to joining Rhodia, Mr. Gress spent fourteen years at FMC Corporation where he worked in various managerial capacities in Strategic Planning, Business, Operations and Supply Chain. From 1977 to 1980, Mr. Gress worked at Ford Motor Company in various capacities within the Plastics, Paint and Vinyl Division. Mr. Gress earned a B.S.E. in Chemical Engineering from Princeton University and an M.B.A. from Harvard Business School.
|
Gary Cappeline
|
|
|
|
|
Director Mr. Cappeline currently serves as an Operating Partner of AEA Investors LLC, a private equity investment fund headquartered in New York City. Before joining AEA in 2007, Mr. Cappeline was president and chief operating officer of Ashland Inc., a diversified chemical company, to which he returned in 2002 after service as a senior executive in the chemical sectors at Englehard Corporation and Honeywell International. He also served as chemical industry partner at Bear Stearns Merchant Bank. Mr. Cappeline currently serves on the board of directors of Unifrax Corporation, a leading producer of high temperature insulation products for a wide variety of industrial applications. He previously served as a board and executive committee member of the American Chemistry Council, a chemical industry trade association.
|
|
Amado Cavazos
|
|
|
|
|
Director Amado Cavazos was elected as a director of Innophos in June 2008. Mr. Cavazos retired from Du Pont, S.A. de C.V. in 2003 after holding numerous management and executive positions. From 1996 to 1997 and again from 2000 to 2003 Mr. Cavazos served as Director of Coatings Businesses for Mexico and Central America. He was Group Director of Du Pont Mexico from 1993 to 1995 and Director of Corporate Planning from 1989 to 1993. During this time he represented Du Pont on several Boards of Directors including Nylon de México, Tetraetilo de México, Química Fluor and Industrias Tecnos. From 1982 to 1986, Mr. Cavazos served as Group Director/General Manger for Du Pont Mexico and for three of its joint ventures, reporting directly to the Boards of Directors of those entities: Pigmentos y Productos Químicos, La Domincia and Química Fluor. Mr. Cavazos earned a B.S. in Chemical Engineering from Virginia Tech and an M.B.A. from Instituto Technológico de Monterrey. Between 1990 and 2003, Mr. Cavazos served as a member and later as Chairman of the Board of Asociación Nacional de la Industria Química, a chemical industry trade association in Mexico.
|
|
Linda Myrick
|
|
|
|
|
Director Linda Myrick is Vice President & General Manager, Scott Medical Products, a division of Scott Specialty Gases, Inc. ("SSG"), headquartered in Allentown, PA. Before joining SSG in 2004, she served as an independent member of the Board of Directors of Berwind Pharmaceutical Services, Inc., West Point, PA and from 2001 to 2003 held various executive management positions with Rhodia, Inc. including Vice President & General Manager—North America, Home, Personal Care & Industrial Ingredients, and, until September 2002, Vice President & General Manager—North America (US and Canada), Specialty Phosphates. Prior to joining Rhodia, Ms. Myrick held a number of positions in marketing, strategic planning and business management with FMC Corporation, Philadelphia, PA. Ms. Myrick earned a B.S. in Chemical Engineering from the University of Delaware and an M.B.A. from the Wharton Graduate School of the University of Pennsylvania. Ms. Myrick is a member of our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Our board of directors has determined that Ms. Myrick is independent as defined in applicable NASDAQ and SEC rules and regulations.
|
|
Karen Osar
|
|
|
|
|
Director Ms. Osar was the Executive Vice President and Chief Financial Officer of Chemtura Corporation, a $4.0 billion specialty chemicals manufacturer headquartered in Connecticut, where she had responsibility for accounting, financial reporting, treasury, tax, financial planning and investor relations functions from 2004 through Chemtura's formation in 2005 until her retirement in March 2007. From 1999 through 2003, she served first as Chief Financial Officer of Westvaco Corporation and subsequent to its merger with Mead Corporation in 2002, Senior Vice President and CFO of MeadWestvaco Corporation, primarily a provider of packaging solutions and products to major branded goods manufacturers. She also held the position of Vice President and Treasurer of Tenneco, Inc., an industrial conglomerate, from 1994 to 1999. Previously she served as Managing Director, Investment Banking, at JP Morgan and Company. Ms. Osar currently serves as a director of the BNY Hamilton Funds, an affiliated group of mutual funds advised by the Bank of New York Mellon, where she chaired the audit committee from 1999-2006, Webster Financial Corporation, a bank holding company, since 2006 and SAPPI Ltd, a global pulp and paper company whose shares are listed on the New York Stock Exchange.
|
|
John M. Steitz
|
|
|
|
|
John M. Steitz is Executive Vice President and Chief Operating Officer of Albemarle Corporation, a leading global developer, manufacturer and marketer of highly engineered specialty chemicals, including polymer additives, catalysts and fine chemicals, a position he has held since 2007, having previously served as Albemarle's Senior Vice President, Global Business Operations. Prior to joining Albemarle in 2000, Mr. Steitz was Vice President and General Manager of Mallinckrodt Incorporated's Pharmaceutical Chemicals Division.
|
|
Stephen Zide
|
|
|
|
|
Director Stephen Zide is a director of Innophos. Mr. Zide has been a Managing Director of Bain Capital since 2001 and affiliated with the firm since 1997. From 1998 to 2000, Mr. Zide was a Managing Director of Pacific Equity Partners, a private equity firm in Sydney, Australia. Prior to joining Bain Capital, Mr. Zide was a partner at the law firm of Kirkland & Ellis LLP, where he was a founding member of the New York office and specialized in representing private equity and venture capital firms. Mr. Zide is also a director of Broder Bros., Co., Keystone Automotive Operations, Inc. and Sensata Technologies B.V.
|
